EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

Corporate Breaking News

Home : EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

Dec 19 2022	EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology
STOCKHOLM, Dec. 19, 2022 /PRNewswire/ -- EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced today that it had raised €21 million in a Series B financing round. New investors, including Almi Invest...


Source:https://www.prnewswire.com:443/news-releases/enginzyme-raises-21-million-in-series-b-to-accelerate-the-commercialisation-of-its-cell-free-biomanufacturing-technology-301705922.html

Related News
» North America last mile delivery market: Growth opportunities led by ArcBest Corp. and AxleHire - Technavio » Initial plan of development completed for Blue Star's world-class Las Animas helium project